Objective: To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices.
Design And Methods: Three brands of urine and urine/serum hCG POCT devices were verified.
Results: Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices. Alternative devices were not affected. The hCG test performance is not influenced.
Conclusions: Gelofusine affects specifically the quality control performance of the QuickVue hCG POCT devices.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clinbiochem.2010.08.017 | DOI Listing |
Publication Analysis
Top Keywords
hcg poct
12
poct devices
12
gelofusine quality
8
quality control
8
control performance
8
performance quickvue
8
human chorionic
8
chorionic gonadotropin
8
succinylated gelatin
8
gelatin performance
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!